.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
CTPharma is stocked at 70 licensed dispensaries across Connecticut, with the deepest coverage in New Haven, Bridgeport, Danbury, Hamden, and Newington. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
CTPharma’s mix in July 2026 concentrated in Pre-Roll at 40.37% share with a month-over-month lift of 4.08% but a year-over-year decline of 70.40%, while Vapor Pens held 24.03% share with a 10.51% MoM increase and an 87.72% YoY drop. Flower accounted for 22.99% share but contracted 37.64% MoM and 91.69% YoY, contrasted with Concentrates at 9.53% share rising 47.88% MoM despite a 58.28% YoY decrease; Topical at 3.08% share advanced 22.85% MoM with an 18.69% YoY pullback. The combination of Pre-Roll anchoring share at rank 6 in Connecticut and the concurrent MoM rebound in three of five categories implies near-term volume is consolidating in quicker-turn formats while legacy Flower is shedding weight in the mix.
The shift toward Pre-Roll and Vapor Pens MoM growth of 4.08% and 10.51%, alongside a 47.88% MoM spike in Concentrates and a 22.85% MoM rise in Topical, indicates CTPharma is tilting toward convenience-led and potency-driven segments as Flower retreats 37.64% MoM and 91.69% YoY. With an average price nearly flat YoY at -1.09% and Pre-Roll pricing at $29.62 against category share of 40.37%, maintaining rank 6 in Connecticut for Pre-Roll suggests the brand’s defensible position centers on accessible price tiers and ready-to-use formats rather than bulk Flower, implying resource allocation should prioritize Pre-Roll depth and complementary inhalable innovation over broad Flower assortment.
Competitive Landscape
CTPharma sits at rank #6 in CT Pre-Roll for July 2026, a drop of 5 positions from its peak at #1 in January 2026 and down 4 spots from its April 2026 position at #2, while its year-over-year rank change is +1 from July 2025. In the same period, Theraplant is at #1 with a +2 YoY rank gain and +76.49% YoY sales growth, and Comffy climbed to #2 with a +9 YoY rank change and +217.86% YoY sales growth, indicating share is consolidating above CTPharma as it slides from #2 to #6 within three months. This trajectory implies CTPharma’s category position is shifting from leader to follower, and without reversing multi-month rank losses against faster-rising rivals, its shelf visibility and velocity are likely to erode further.
Notable Products
E85 THCA Infused Shorties Pre-Roll 5-Pack (2g) posted the standout move in July 2026 with a +148% month-over-month surge and captured rank 1, while GMO Purps Shorties Pre-Roll 5-Pack (2g) slid -14% to rank 2, indicating share consolidation at the top rather than broad-based lift. Applescotti Shorties Pre-Roll 5-Pack (2g) fell -29% and sat at rank 7, and Lemon Cherry Sherb (3.5g) declined -47% at rank 8, creating a widening performance gap between infused pre-rolls and select flower SKUs. Four of the top ten are Pre-Roll SKUs, including two infused variants in the top six, and the top SKU alone generated $66,199, pointing to a consumer tilt toward high-potency, convenience formats. The pattern implies CTPharma’s commercial direction is concentrating around infused pre-roll leadership while de-emphasizing slower-moving flower lines.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
